Skip Ribbon Commands
Skip to main content

Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

19 May 2022

Therapeutic Drug Monitoring (TDM) is an area of interest in the recent Inflammatory Bowel Disease (IBD) field. It has emerged as a tool to understand and predict patient's response to biologic treatment. TDM provides better guide on therapeutic decisions regarding biologic escalation, withdrawal and switch. Hence, it helps to optimize the biologic therapy and provides personalized treatment. Various factors affect TDM implementation in practice as well as results interpretation. This lecture aims to discuss the strategies of using TDM in the IBD management, review biologic TDM interpretation, explain the practical issues of TDM use as well as discuss current and future roles and opportunities of TDM use in patients receiving biologic treatment.

After the lecture, the participants will be able to gain an understanding on:

  • Current strategy of using TDM in guiding IBD management
  • Biologics and antidrug antibodies interpretation
  • Advantages and challenges of biologic TDM
  • Future roles and opportunities of TDM in personalized medicine

Click here for more lecture details.


To register (internet access is required), scan the QR code or click on the web link. Registration closes on 29 April 2022, Friday.

QR Code for CPE Lecture Registration_19 May 2022.png

Upon registration, participants agreed to PGAHI Terms & Conditions.  Kindly note that PGAHI reserves the right of final decision on lecture registration.

Lecture Details


19 May 2022, Thursday



6.30 pm - 7.30 pm



60 minutes






Zoom Cloud Meetings


Registration Closing Date:

29 April 2022, Friday


Target Audience:



(Zoom Capacity: 500

This lecture will be conducted via Zoom Cloud Meetings app. For ease of accessing the lecture, please download/update Zoom Cloud Meetings app. Details of the lecture meeting link will be sent to the successful registrants nearer the lecture date.)